从EURETINA最新指南看视网膜静脉阻塞诊疗策略的变化  

Changes of diagnosis and treatment strategies of retinal vein occlusion according to EURETINA updated guidelines

作　　者：戴虹[1] 卢颖毅[1] 许晶晶 

机构地区：[1]北京医院眼科国家老年医学中心中国医学科学院老年医学研究院,100730

出　　处：《中华实验眼科杂志》2020年第1期1-3,共3页Chinese Journal Of Experimental Ophthalmology

摘　　要：视网膜静脉阻塞(retinal vein occlusion,RVO)是严重危及视功能的常见疾病,在临床治疗策略和方案上并未完全形成共识,国内至今也未见相关指南和共识发表,近期新的国际指南发布对RVO治疗方法和管理策略有了更为全面、清晰的推荐和建议,了解并解读相关指南可为临床实践提供参考,对规范和指导诊疗提供帮助。Retinal vein occlusion(RVO)is one of the most common diseases severely threatening visual acuity.There is not a complete consensus on the clinical treatment strategies and schemes,and no guideline or consensus has been published in China.The publication of the latest international guidelines has provided more comprehensive and clear suggestions and advices for treatment and management strategies for RVO.Reading and understanding those guidelines could provide references for clinical practice,and offer help for standard diagnosis and treatment.

关 键 词：视网膜静脉阻塞 管理 治疗策略 

分 类 号：R774.1[医药卫生—眼科]